Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-26T05:44:04.554Z Has data issue: false hasContentIssue false
  • English
  • Français

Placebo: The Best Pill of All

Published online by Cambridge University Press:  07 November 2014

Dan J. Stein  and
Helen Mayberg
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Pearls in Clinical Neuroscience
Information
CNS Spectrums , Volume 10 , Issue 6 , June 2005 , pp. 440 - 442
Copyright
Copyright © Cambridge University Press 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Leber, P. The use of placebo control groups in the assessment of psychiatric drugs: an historical context. Biol Psychiatry. 2000;47:699–706.CrossRefGoogle ScholarPubMed
2. Khan, A, Khan, S, Brown, WA. Are placebo controls necessary to test new antidepressants and anxiolytics? Int J Neuropsychopharmacol. 2002;5:193–197.CrossRefGoogle ScholarPubMed
3. Hrobjartsson, A, Gotzsche, PC. Is the placebo powerless? Update of a systematic review with new randomized trials comparing placebo with no treatment. J Intern Med. 2004;256:91–100.CrossRefGoogle ScholarPubMed
4. McDonald, CJ, Mazzuca, SA, McCabe, GP Jr. How much of the placebo ‘effect’ is really statistical regression? Star Med. 1983;2:417–427.Google ScholarPubMed
5. Brody, H. Three perspectives on the placebo response: Expectancy, conditioning, and meaning. Adv Mind Body Med. 2000;16:211–232.Google ScholarPubMed
6. Kirsch, I. Conditioning, expectancy, and the placebo effect: comment on Stewart-Williams and Podd. Psychol Bull. 2004;130:341–343.CrossRefGoogle ScholarPubMed
7. Charney, DS, Nemeroff, CB, Lewis, L, et al. National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry. 2002;59:262–270.CrossRefGoogle ScholarPubMed
8. Moncrieff, J, Wessely, S, Hardy, R. Active placebos versus antidepressants for depression. Cochrane Database Syst Rev. 2004;1:CD003012.Google Scholar
9. Benedetti, F, Amanzio, M. The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin. Prog Neurobiol. 1997;51:109–125.CrossRefGoogle Scholar
10. Wager, TD, Rilling, JK, Smith, EE, et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science. 2004;303:1162–1167.CrossRefGoogle ScholarPubMed
11. Mayberg, HS, Silva, JA, Brannan, SK, et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry. 2002;159:728–737.CrossRefGoogle ScholarPubMed
12. Leuchter, AF, Cook, IA, Witte, EA, et al. Changes in brain function of depressed patients during treatment with placebo. Am J Psychiatry. 2002;159:122–129.CrossRefGoogle ScholarPubMed
13. Petrovic, P, Kalso, E, Petersson, KM, Ingvar, M. Placebo and opioid analgesia–imaging a shared neuronal network. Science. 2002;295:1737–1740.CrossRefGoogle ScholarPubMed
14. Levine, JD, Gordon, NC, Fields, HL. The mechanism of placebo analgesia. Lancet. 1978;2:654–657.CrossRefGoogle ScholarPubMed
15. Amanzio, M, Pollo, A, Maggi, G, Benadetti, F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001;90:205–215.CrossRefGoogle ScholarPubMed
16. de la Fuente-Fernandez, R, Phillips, AG, Zamburlini, MJ, et al. Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res. 2002;136:359–363.CrossRefGoogle Scholar
17. de la Fuente-Fernandez, R, Ruth, TJ, Sossi, V, et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science. 2001;293:1164–1166.CrossRefGoogle ScholarPubMed
18. Fiorillo, CD, Tobler, PN, Schultz, W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science. 2003;299:1898–1902.CrossRefGoogle ScholarPubMed
19. Benedetti, F, Colloca, L, Torre, E, et al. Placebo-responsive Parkinson patients showed decreased activity in single neurons of subthalamic nucleus. Nat Neurosci. 2004;7:587–588.CrossRefGoogle ScholarPubMed
20. Shapiro, AK, Shapiro, E. The Powerful Placebo: From Ancient Priest to Modern Physician. Baltimore, MD: Johns Hopkins University Press; 2001.Google Scholar
21. Guess, HA, Kleinman, A, Kusek, JW, Engel, LW. The Science of the Placebo: Toward an Interdisciplinary Research Agenda. London: BMJ Books; 2002.Google Scholar
22. Brody, H. Placebos and the Philosophy of Medicine: Clinical, Conceptual, and Ethical Issues. Chicago, IL: University of Chicago Press; 1980.Google Scholar
23. Harrington, A. The Placebo Effect: An Interdisciplinary Collaboration. Cambridge, Mass: Harvard University Press; 1999.Google Scholar
24. White, L, Tursky, B, Schwartz, GE. Placebo: Theory, Research, and Mechanisms. New York, NY: Guilford Press; 1985.Google Scholar
25. Moerman, DE. Meaning, Medicine and the ‘Placebo Effect.’ Cambridge, Mass: Cambridge University Press; 2002.CrossRefGoogle ScholarPubMed
26. Bendesky, A, Sonabend, AM. On Schlepfuss' path: the placebo response in human evolution. Med Hypotheses. 2005;64:414–416.CrossRefGoogle ScholarPubMed
27. Evans, D. Placebo: The Belief Effect. New York, NY: HarperCollins; 2003.Google Scholar
28. McMillan, FD. The placebo effect in animals. J Am Vet Med Assoc. 1999;215:992–999.CrossRefGoogle ScholarPubMed
29. Barksy, AJ, Saintfort, R, Rogers, MP, Borus, JF. Nonspecific medication side effects and the nocebo phenomenon. JAMA. 2002;287:622–627.Google Scholar
30. Posternak, MA, Zimmerman, M, Keitner, GI, Miller, IW. A reevaluation of the exclusion criteria used in antidepressant efficacy trials. Am J Psychiatry. 2002;159:191–200.CrossRefGoogle ScholarPubMed
31. Quitkin, FM, Raskin, JG, Markowitz, JM, et al. Use of pattern analysis to identify true drug response: a replication. Arch Gen Psychiatry. 1987;44:259–264.CrossRefGoogle ScholarPubMed
32. Nierenberg, AA, Quitkin, FM, Kremer, C, et al. Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse. Neuropsychopharmacology. 2004;29:1012–1018.CrossRefGoogle ScholarPubMed
33. Zimbroff, DL. Patient rater education of expectations in clinical trials (PREECT). J Clin Psychopharmacol. 2001;21:251–252.CrossRefGoogle ScholarPubMed
34. Walsh, BT, Seidman, SN, Sysko, R, Gould, M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA. 2002;287:1840–1847.CrossRefGoogle ScholarPubMed
35. Rickels, K. Non-Specific Factors in Drug Therapy. Springfield, IL; Charles C. Thomas: 1968.Google Scholar
36. Di Blasi, Z, Kaptchuk, TJ, Weinman, J, Kleijnen, J. Informing participants of allocation to placebo at trial closure: postal survey. BMJ. 2002;325:1329.CrossRefGoogle ScholarPubMed
37. Kirsch, I, Weixel, LJ. Double-blind versus deceptive administration of a placebo. Behav Neurosci. 1988;102:319–323.CrossRefGoogle ScholarPubMed
38. Kent, MA, Camfield, CS, Camfield, PR. Double-blind methylphenidate trials: practical, useful, and highly endorsed by families. Arch Pediatr Adolesc Med. 1999;153:1292–1296.CrossRefGoogle ScholarPubMed